The treatment-related mortality score is associated with non-fatal adverse events following intensive AML induction chemotherapy

about

TACL'ing supportive care needs in pediatric early phase clinical trials for acute leukemia: A report from the therapeutic advances in childhood leukemia & lymphoma (TACL) consortium supportive care committee.

P2860

Q46516037-A7E8D3BF-D2E4-4995-9FFE-4A551D054A11

P2860

The treatment-related mortality score is associated with non-fatal adverse events following intensive AML induction chemotherapy

Item

http://www.wikidata.org/entity/Q42358970

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

The treatment-related mortalit ...... ive AML induction chemotherapy

@en

The treatment-related mortalit ...... ive AML induction chemotherapy

@nl

type

Item

label

The treatment-related mortalit ...... ive AML induction chemotherapy

@en

The treatment-related mortalit ...... ive AML induction chemotherapy

@nl

prefLabel

The treatment-related mortalit ...... ive AML induction chemotherapy

@en

The treatment-related mortalit ...... ive AML induction chemotherapy

@nl

P1476

The treatment-related mortalit ...... ive AML induction chemotherapy

@en

P2093

E H Estey

http://www.w3.org/2001/XMLSchema#string

M Othus

http://www.w3.org/2001/XMLSchema#string

S A Buckley

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

Prediction of adverse events during intensive induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes.

Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment

Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy

A prospective survey of febrile events in hematological malignancies.

Declining rates of treatment-related mortality in patients with newly diagnosed AML given 'intense' induction regimens: a report from SWOG and MD Anderson.

Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.

P2888

bcj.2014.97

P304

e276

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BCJ.2014.97

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Roland B Walter

P577

2015-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1046443479

http://www.w3.org/2001/XMLSchema#string

P698

25635529

http://www.w3.org/2001/XMLSchema#string

P932

5404219

http://www.w3.org/2001/XMLSchema#string

The treatment-related mortality score is associated with non-fatal adverse events following intensive AML induction chemotherapy

about

P2860

P2860

The treatment-related mortality score is associated with non-fatal adverse events following intensive AML induction chemotherapy

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P6179

P698

P932